Reckitt Benckiser beats earnings forecasts

LONDON Wed Feb 13, 2013 2:12am EST

LONDON Feb 13 (Reuters) - Britain's Reckitt Benckiser beat full-year earning expectations as the maker of Strepsils and Mucinex benefited from an unusually heavy U.S. cold and flu season in the final quarter.

Full-year adjusted earnings per share was 264.4 pence, compared to Thomson Reuters I/B/E/S estimates of 246.8 pence and a company-supplied forecast of 249 pence.

An early and unusually intense flu season in North America has pushed up business for hospitals, pharmacies and the makers of tissues and cold remedies.

A couple walks along the rough surf during sunset at Oahu's North Shore, December 26, 2013. REUTERS/Kevin Lamarque

Find your dream retirement town

Florida? Hawaii? Reuters has teamed up with Zillow to give you the power to customize a list of your best places to retire.  Video | Full Article